News

Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study ...
Cosmopolitan6d
The 13 Best Retinols Tested and Approved by Editors and Dermatologists for the Smoothest Skin
BG Quick retinal 101 first: Retinal only needs one step to convert in your skin to retinoic acid, which is what helps boost your cell turnover, making it the strongest retinal available ...